Brief: Caplin Point Laboratories Gets Two Observations Post USFDA Inspection At Steriles Injectable Site

Caplin Point Laboratories

17/06/2019 07:06

June 17 (Reuters) - Caplin Point Laboratories Ltd  CAPL.NS :
    * SAYS US FDA INSPECTION COMPLETED AT CAPLIN STERILES
INJECTABLE
SITE
    * SAYS AT END OF THE SCHEDULED GMP INSPECTION, THERE WERE
ONLY TWO
OBSERVATIONS
    * SAYS OBSERVATIONS MADE WERE NOT REPEAT OBSERVATIONS OR
RELATED
TO DATA INTEGRITY

Source text: http://bit.ly/2WQDzPq
Further company coverage:  CAPL.NS 

 ((Reuters.Briefs@thomsonreuters.com;))